BE844745A - Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation - Google Patents

Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation

Info

Publication number
BE844745A
BE844745A BE169437A BE169437A BE844745A BE 844745 A BE844745 A BE 844745A BE 169437 A BE169437 A BE 169437A BE 169437 A BE169437 A BE 169437A BE 844745 A BE844745 A BE 844745A
Authority
BE
Belgium
Prior art keywords
andro
sten
derivatives
products
preparation
Prior art date
Application number
BE169437A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE844745A publication Critical patent/BE844745A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/005—Degradation of the lateral chains at position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE169437A 1975-08-01 1976-07-30 Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation BE844745A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2534911A DE2534911C2 (de) 1975-08-01 1975-08-01 Verfahren zur Herstellung von 5-Androsten-17-on-Derivaten

Publications (1)

Publication Number Publication Date
BE844745A true BE844745A (fr) 1977-01-31

Family

ID=5953265

Family Applications (1)

Application Number Title Priority Date Filing Date
BE169437A BE844745A (fr) 1975-08-01 1976-07-30 Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation

Country Status (17)

Country Link
US (1) US4170518A (sv)
JP (1) JPS5238090A (sv)
AT (1) AT361639B (sv)
BE (1) BE844745A (sv)
CH (1) CH624415A5 (sv)
CS (1) CS191981B2 (sv)
DD (3) DD127114A5 (sv)
DE (1) DE2534911C2 (sv)
DK (1) DK140172C (sv)
FR (1) FR2319650A1 (sv)
GB (1) GB1576129A (sv)
HU (1) HU183019B (sv)
IE (1) IE44308B1 (sv)
IT (1) IT1065955B (sv)
NL (1) NL7608540A (sv)
SE (1) SE420731B (sv)
SU (1) SU697053A3 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2632677A1 (de) * 1976-07-16 1978-01-26 Schering Ag Verfahren zur herstellung von androstan-17-on-derivaten und deren verwendung
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
WO1994016709A2 (en) * 1993-01-19 1994-08-04 Endorecherche Inc. Therapeutic uses and delivery systems of dehydroepiandrosterone
AU8779898A (en) * 1997-08-11 1999-03-01 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
EP1149839A1 (en) * 2000-04-28 2001-10-31 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. Progesterone substantially free of delta14-pregnene-3,20-dione
KR100432054B1 (ko) * 2001-05-11 2004-05-17 (주)유진사이언스 스테롤로부터 4-안드로스텐-3,17-디온/안드로스타-1,4-디엔-3,17-디온으로의 뛰어난 전환능을 가지는 미생물 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione

Also Published As

Publication number Publication date
IE44308B1 (en) 1981-10-21
HU183019B (en) 1984-04-28
DD131562A5 (de) 1978-07-05
DK140172B (da) 1979-07-02
SU697053A3 (ru) 1979-11-05
DK343976A (da) 1977-02-02
FR2319650B1 (sv) 1980-05-09
FR2319650A1 (fr) 1977-02-25
DD131561A5 (de) 1978-07-05
NL7608540A (nl) 1977-02-03
DE2534911C2 (de) 1985-04-18
CH624415A5 (sv) 1981-07-31
AT361639B (de) 1981-03-25
GB1576129A (en) 1980-10-01
IE44308L (en) 1977-02-01
DK140172C (da) 1979-11-26
JPS5238090A (en) 1977-03-24
DE2534911A1 (de) 1977-02-17
JPS6253160B2 (sv) 1987-11-09
DD127114A5 (sv) 1977-09-07
SE420731B (sv) 1981-10-26
ATA565676A (de) 1980-08-15
CS191981B2 (en) 1979-07-31
IT1065955B (it) 1985-03-04
SE7608575L (sv) 1977-02-02
US4170518A (en) 1979-10-09

Similar Documents

Publication Publication Date Title
BE872210A (fr) Procede de preparation de nitrodiarylamines et nouveaux produits ainsi obtenus
BE856860A (fr) Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation
BE843441A (fr) Procede de preparation de polyamines produits obtenus et en derivant
FR2306214A1 (fr) Procede de preparation de 17 a-ester-21-halopregnanes et nouveaux produits ainsi obtenus
FR2274299A1 (fr) Procede de preparation de 7b-acylamino-7a-alcoxycephalosporines et 6b-acylamino-6a-alcoxy-penicillines, nouveaux produits obtenus et leur application
BE832664A (fr) Procede perfectionne de preparation de cyanoghanidines et produits obtenus
BE839929A (fr) Produits alimentaires et leur procede de preparation
BE843019A (fr) Procede de preparation de produits alimentaires.
BE854167A (fr) Procede de preparation de derives de n-phosphono-methylglycine, nouveaux produits ainsi obtenus et leur utilisation comme herbicides
FR2319626A1 (fr) Procede de preparation de dinitriles insatures et nouveaux produits ainsi obtenus
FR2316185A1 (fr) Procede de preparation de fluorures de soufre et nouveaux produits ainsi obtenus
FR2306994A1 (fr) Procede de preparation de phosphonate et nouveaux produits ainsi obtenus
FR2317924A1 (fr) Procede de production de derives d'ortho-aminobutyrophenone, nouveaux produits ainsi obtenus et leur utilisation comme agents analgesiques et antipsychose
BE849557A (fr) Procede de preparation de derives de 4-androstene-3, 17-dione, et produits obtenus
FR2335479A1 (fr) Procede de preparation de d-mannitol et nouveau produit ainsi obtenu
FR2306702A1 (fr) Procede de preparation de sterolglucosides facilement absorbable et nouveaux produits ainsi obtenus
PT65380B (fr) Procede de preparation de nouveaux derives phenoxy
BE832665A (fr) Procede perfectionne de preparation de cyanoguanidines et produits obtenus
BE844745A (fr) Procede de preparation de derives de 5-andro-sten-17-one, produits ainsi obtenus et leur utilisation
FR2351934A1 (fr) Procede de preparation de derives de cyclopropane et produits obtenus
BE840871A (fr) Derives de ll-oxo-prostaglandine et leur procede de preparation
FR2303014A1 (fr) Procede de preparation de derives de 4-oxo-hexahydro-pyrazino-isoquinoleine
FR2300755A1 (fr) Procede de preparation de derives de beta-dihalogenoethenylcyclopropane
FR2317251A1 (fr) Procede de preparation de produits ceramiques
BE854622A (fr) Procede de preparation de polyesters et produits ainsi obtenus

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SCHERING A.G.

Effective date: 19900731